信義儲電(08328.HK)供股獲超購約365.73%
格隆匯12月17日丨信義儲電(08328.HK)公吿,所有供股條件已獲達成,且供股於2021年12月13日下午四時正成為無條件。供股所得款項淨額約為2.28億港元。
於2021年12月10日下午四時正,合共收到109份有關3.02億股供股股份的有效接納及申請,佔根據供股所發售的6484.6萬股供股股份總數的約465.73%。
鑑於供股股份獲超額認購,董事會認為參照各份申請項下所申請的額外供股股份數目按約2.18%的比例分配530萬股供股股份予申請額外供股股份的合資格股東屬公平及公正。
預期繳足股款供股股份將於2021年12月21日上午九時正起在聯交所開始買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.